Publications by authors named "Kevin Kanu"
Article Synopsis
- Nine-valent human papillomavirus (9vHPV) vaccines can be given in two doses, and this study explores the effects of extending the time between doses beyond the typical 6 to 12 months.
- The study involved 146 adolescents who received their second 9vHPV dose between 12 to 53 months after the first dose, and results showed that antibody levels increased significantly after the second dose, with all participants showing a positive response a month later.
- Adverse events were mostly mild, such as injection site reactions, and no serious side effects were reported, suggesting that longer intervals between doses are safe and effective for the 9vHPV vaccination.
